Home

Features

Departments

News & Trends

CME
   May
      Article
      Instructions
      Exam

   September
      Article
      Instructions
      Exam

   November
      Article
      Instructions
      Exam

     



Continuing Medical Education



Laser Thermokeratoplasty for Hyperopia and Presbyopia


Release Date: November 2000

Last Review Date: October 2000

Expiration Date: November 30, 2001

Target Audience: Ophthalmologists

Statement of Need: Two of the greatest growth potential areas of refractive surgery are for the treatment of hyperopia and presbyopia. With over 70 million hyperopes in the United States, it is important that ophthalmologists remain informed of the treatment options for these patients.

Learning Objectives:
  1. List the properties, advantages and benefits of the Hyperion laser thermokeratoplasty.
  2. Describe the surgical procedure and post-operative care of Hyperion LTK.
  3. Identify other treatment options for hyperopia.
  4. Explain other applications of holmium laser thermokeratoplasty.


Estimated Time to Complete the Activity: 1 hour

Faculty/Editorial Board: Daniel S. Durrie, MD

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Postgraduate Institute for Medicine and Review of Ophthalmology. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians and takes responsibility for the content, quality, and scientific integrity of this continuing medical education activity.

Designation Statement: The Postgraduate Institute for Medicine designates this educational activity for a maximum of one (1) hour in category 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Disclosure Statement: Dr. Durrie has disclosed his status as a consultant for and recipient of grant/ research support from Bausch & Lomb, KeraVision, Nidek, and Refractec. The Postgraduate Institute for Medicine does not view the existence of these relationships to imply bias or that the value of the material is decreased. The content of this activity was planned to be balanced, objective, and scientifically rigorous. Occasionally, authors may express opinions that represent their own viewpoint. Conclusions drawn by participants should be derived from objective analysis of scientific data.

Disclaimer: Information presented in this program may include unlabeled use(s) of drugs/ products.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


This CME article is sponsored by the Postgraduate Institute for Medicine and supported by an unrestricted educational grant from Sunrise Technologies.

Click here to participate in this CME program.